Advisors

Bill Robbins, CEO of Convergent Venture LLC. Mr. Robins is an experienced manager and entrepreneur with 17 years of business development, product development, product management and research experience in the pharmaceutical, biotechnology, medical technology and contract clinical research industries. Previously, He served as V.P of Business Development with Bio-Imaging Technologies, a medical imaging and clinical research company. During his tenure, the company executed an IPO, a $1.25 million strategic partnership with Corning Pharmaceutical Services, and sold over $6 million in clinical research contracts to companies such as Immunex, Nycomed, Cordis, Pfizer and Janssen. He has held marketing and new product development positions at Warner- Lambert and account management positions at the medical division of Grey Advertising, Inc., in New York. Mr. Robbins has experience in the private equity, venture capital and public equity markets.

Mr. Robbins holds an A.B in psychology & biology from Dartmouth College and a M.B.A. in marketing from Columbia Business School. He is a member of the Capital Access Committee of the Southern California Biomedical Council, President of the Columbia Business School of Southern California and a board member of the Dartmouth Club of Los Angeles.

Samuel Hao is an internal business advisor and consultant for China Healthcare Consulting in China. He is also a general marketing and sales director for Western China Pharmaceutical, a leading pharmaceutical company in Sichuan. Prior to joining WCP, Mr. Hao took various senior management positions in foreign pharmaceutical companies in China including regional sales and field training manager for Pfizer and research executive for Isis Marketing Research Company. Mr. Hao has strong experience in strategic planning and marketing research for pharmaceutical, biopharmaceutical and medical device products.

Maurille Fournier, Ph.D. is a Professor at the University of Massachusetts at Amherst for the Department of Biochemistry. Dr. Fournier has more than 30 years research experience in molecular biology, and is a highly regarded biochemist in the small RNA world with over 100 publications in scientific journals. He was the first to discover the biological functions of more than 100 RNA genes in humans and held several key patents in the field. He was the recipient of multiple million dollar research grants from National Institutes of Health in the United States. Beside his academic achievements, Dr. Fournier is also a successful administrator. He served as Chairman of Molecular and Cellular Biology at the University of Massachusetts at Amherst. He received a Bachelor degree in organic chemistry, and Ph.D. in biochemistry from Dartmouth College in the United States. 

David Lin is an internal business advisor/consultant for China Healthcare Consulting in China. He also serves as an assistant to the CEO of Sichuan Biological Products Inc., a leading vaccine and blood preparation manufacturer and research institute in China. Mr. Lin has 15 years of quality control, new vaccine development, and operating management experience in the biopharmaceutical industry. During his tenure, he was responsible for the approvals of several biopharmaceutical products including interferon, vaccines for hepatitis B and meningitis. He is a member of the standing committee for drug regulation and evaluation in China.

Winfried Pick, M.D, associate professor of Institutes of Immunology at University of Vienna Medical School in Austria, a world leading research institute in immunology. Dr. Pick has more than 15 years research and clinical experiences in immunology, and has published dozen of research articles in scientific journals. He graduated with M.D. with honors from the University of Vienna Medical School, and served as assistant professor after the graduation. He was awarded the Best Thesis Dissertation for his M.D. training. During 1997-2000, he spent his sabbatical in Harvard Medical School and made several important discoveries in the area of AIDS research.